Semaglutide vs Tirzepatide:
Which Is Right for You?
Both are powerful GLP-1 medications. Both are available through Open Water Rx. Here is everything you need to make an informed decision, or let your licensed medical provider decide for you.
Compounded medications are not FDA-approved products. Licensed provider evaluation required.
Patient Profiles
Which Medication Fits Your Goals?
These are general guidelines. Your licensed medical provider makes the final recommendation based on your individual health profile.
Choose Semaglutide if...
- You are new to GLP-1 medications
- Budget is a primary consideration (semaglutide from $249/mo vs tirzepatide from $339/mo)
- You prefer a medication with a longer clinical track record (10+ years)
- You are sensitive to new medications and want to start conservatively
- Your weight loss goal is 15–20% of body weight
Choose Tirzepatide if...
- You want maximum weight loss results (20–22% in trials)
- You have type 2 diabetes or insulin resistance
- You have a higher BMI and want the most effective option
- You have tried semaglutide and want to step up
- You are comfortable with a newer medication with strong evidence
Not sure which to choose? That is completely normal. Complete your health evaluation and your licensed medical provider will recommend the best option for you. No guesswork required.
Let My Provider Decide →Full Breakdown
Semaglutide vs Tirzepatide: Side-by-Side
| Category | Semaglutide From $249/mo | Tirzepatide From $339/mo |
|---|---|---|
| Mechanism | GLP-1 receptor agonist (single pathway) | Edge Dual GIP + GLP-1 receptor agonist (two pathways) |
| Avg. Weight Loss (Clinical Trials) | 15–17% of body weight (STEP 1, NEJM 2021) | Edge 20–22% of body weight (SURMOUNT-1, NEJM 2022) |
| Starting Price (Open Water Rx) | Edge $249/mo · prepaid plans may lower the effective monthly rate | $339/mo · prepaid plans may lower the effective monthly rate |
| Injection Frequency | Once weekly | Once weekly |
| Nausea / GI Side Effects | Common during dose escalation; typically resolves | Edge Similar; some patients report slightly less nausea |
| Years of Clinical Data | Edge 10+ years (longer track record) | 4+ years (newer, rapidly growing evidence base) |
| Best For | First-time GLP-1 users, budget-conscious patients, those sensitive to new medications | Higher BMI, type 2 diabetes, patients wanting maximum weight loss |
| FDA Approval Status (Compounded) | Not FDA-approved as compounded product | Not FDA-approved as compounded product |
| Provider Supervision | Yes, independent licensed medical provider | Yes, independent licensed medical provider |
| Shipping | Included if prescribed | Included if prescribed |
Mechanism
GLP-1 receptor agonist (single pathway)
Dual GIP + GLP-1 receptor agonist (two pathways)
Avg. Weight Loss (Clinical Trials)
15–17% of body weight (STEP 1, NEJM 2021)
20–22% of body weight (SURMOUNT-1, NEJM 2022)
Starting Price (Open Water Rx)
$249/mo · prepaid plans may lower the effective monthly rate
$339/mo · prepaid plans may lower the effective monthly rate
Injection Frequency
Once weekly
Once weekly
Nausea / GI Side Effects
Common during dose escalation; typically resolves
Similar; some patients report slightly less nausea
Years of Clinical Data
10+ years (longer track record)
4+ years (newer, rapidly growing evidence base)
Best For
First-time GLP-1 users, budget-conscious patients, those sensitive to new medications
Higher BMI, type 2 diabetes, patients wanting maximum weight loss
FDA Approval Status (Compounded)
Not FDA-approved as compounded product
Not FDA-approved as compounded product
Provider Supervision
Yes, independent licensed medical provider
Yes, independent licensed medical provider
Shipping
Included if prescribed
Included if prescribed
GLP-1 medications have shown substantial weight loss in clinical studies of certain FDA-approved products. Individual eligibility, treatment, and results vary. Compounded medications are not FDA-approved products.
The Science
How Each Medication Works
Semaglutide
GLP-1 Receptor Agonist
Appetite Suppression
Activates GLP-1 receptors in the brain's appetite center, reducing hunger signals and increasing feelings of fullness after smaller meals.
Slows Gastric Emptying
Food moves more slowly through the stomach, prolonging satiety and reducing caloric intake naturally.
Blood Sugar Regulation
Stimulates insulin release in response to meals and suppresses glucagon, improving blood sugar control.
Tirzepatide
Dual GIP + GLP-1 Receptor Agonist
Dual Receptor Activation
Activates both GIP and GLP-1 receptors simultaneously, two complementary pathways that amplify appetite suppression beyond what either receptor alone can achieve.
Enhanced Fat Metabolism
GIP receptor activation improves fat cell metabolism and may reduce the nausea associated with GLP-1 activation alone.
Superior Metabolic Impact
Particularly effective for patients with insulin resistance or type 2 diabetes, improving both weight and metabolic markers simultaneously.
Pricing
What Does Each Medication Cost?
Semaglutide plans start at $249/month and tirzepatide plans start at $339/month. Pricing includes provider review, prescription if approved, shipping included if prescribed, and ongoing support. Some longer-term prepaid plans may lower the effective monthly rate. Pricing and availability are subject to clinical appropriateness and regulatory change.
Injectable Semaglutide
GLP-1 single pathway · Avg. 15–17% body weight loss in trials
- Licensed medical provider review included
- Prescription issued only when clinically appropriate
- Shipping included if medication is prescribed
- Base labs when clinically indicated
- Secure patient messaging
- Ongoing follow-up included
Prepaid plans may lower the effective monthly rate. Subject to clinical appropriateness.
Learn About Semaglutide →Injectable Tirzepatide
Dual GIP/GLP-1 pathway · Avg. 20–22% body weight loss in trials
- Licensed medical provider review included
- Prescription issued only when clinically appropriate
- Shipping included if medication is prescribed
- Base labs when clinically indicated
- Secure patient messaging
- Ongoing follow-up included
Prepaid plans may lower the effective monthly rate. Subject to clinical appropriateness.
Learn About Tirzepatide →Optional care coaching may be available on select programs. Pricing and availability are subject to clinical appropriateness and regulatory requirements.
Semaglutide plans start at $249/month and tirzepatide plans start at $339/month. Pricing includes provider review, prescription if approved, shipping included if prescribed, and ongoing support. Some longer-term prepaid plans may lower the effective monthly rate. Pricing and availability are subject to clinical appropriateness and regulatory change. Compounded semaglutide and tirzepatide are not FDA-approved products.
FAQ
Common Questions
Yes, based on clinical trial data. Tirzepatide's dual GIP/GLP-1 mechanism produces greater average weight loss (20–22%) compared to semaglutide's single GLP-1 pathway (15–17%). However, individual results vary significantly, and both medications are highly effective. Your licensed medical provider will recommend the best option based on your health profile, goals, and medical history.
Both semaglutide and tirzepatide share similar GI side effects, primarily nausea, mild stomach discomfort, and occasional constipation during dose escalation. Some patients report tirzepatide causes slightly less nausea, possibly due to the GIP component's effect on gastric motility. Both medications use a gradual titration schedule to minimize discomfort. Individual tolerance varies.
Yes, switching is possible and some patients do transition from semaglutide to tirzepatide for greater weight loss results. Your licensed medical provider will guide the transition, including appropriate washout periods and starting doses. This decision is made on an individual clinical basis.
Both medications improve blood sugar control. Tirzepatide (the active ingredient in Mounjaro) has shown particularly strong results for type 2 diabetes management due to its dual GIP/GLP-1 mechanism. If you have type 2 diabetes, your licensed medical provider will factor this into their recommendation.
Tirzepatide is a newer, more complex molecule with a dual receptor mechanism. The compounding pharmacy costs for tirzepatide are higher than for semaglutide. Through Open Water Rx, compounded tirzepatide starts at $339/month vs $249/month for semaglutide, both significantly less than retail pharmacy pricing for commercial GLP-1 products.
No. You can indicate your preference on the intake form, but your licensed medical provider will make the final recommendation based on your health profile, BMI, medical history, and goals. Many patients are unsure which medication is right for them. That is exactly what the provider consultation is for.
The Bottom Line
Semaglutide vs Tirzepatide: Which Should You Choose?
Both semaglutide and tirzepatide are highly effective GLP-1 medications for weight loss. The right choice depends on your goals, budget, and health history. Here is the short version:
- Choose semaglutide: if you are new to GLP-1 therapy, budget is a priority, or you prefer a medication with a longer clinical track record. Semaglutide produces an average of 15 to 17 percent body weight loss in clinical trials and starts at $249 per month through Open Water Rx.
- Choose tirzepatide: if you want maximum weight loss results, have type 2 diabetes or insulin resistance, or have already tried semaglutide. Tirzepatide's dual GIP and GLP-1 mechanism produces an average of 20 to 22 percent body weight loss in clinical trials and starts at $339 per month.
- Not sure?: That is completely normal. Complete your health evaluation and your licensed medical provider will recommend the right medication based on your individual health profile, BMI, and goals. No guesswork required.
Weight loss averages are based on published clinical trial data (STEP 1, SURMOUNT-1). Individual results vary and are not guaranteed. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. All prescribing decisions are made by independent licensed medical providers.
Ready to Get Started?
Join the waitlist and your licensed medical provider will recommend the right medication for you. No commitment required.
Join the WaitlistYour Privacy & Cookie Preferences
We use cookies to analyze site traffic and improve your experience. We never sell your data. Google Analytics is only enabled with your consent. Session recording and heatmap tools are disabled unless you accept. Privacy Policy
Semaglutide plans from $249/mo · Tirzepatide plans from $339/mo · No insurance required · Shipping included if prescribed
Early access now open
No credit card required